This result suggests that WNT6 expression associates with glioma increased malignancy independently of the remarkable differences between glioma molecular subtypes (astrocytoma IDHwt, astrocytoma IDHmut, and IDHmut 1p/19q codeleted oligodendroglioma). This evidence concerns the gene WNT6 and astrocytoma (excluding glioblastoma).